0

Liver Disease Collection
 121-140 of 979 Articles
Articles |  15 June 1999
HFE Genotype in Patients with Hemochromatosis and Other Liver Diseases
Bruce R. Bacon, MD; John K. Olynyk, MD; Elizabeth M. Brunt, MD; et al.
Ann Intern Med. 1999;130(12):953-962. doi:10.7326/0003-4819-130-12-199906150-00002
Brief Communications |  16 February 1999
Nefazodone-Induced Liver Failure: Report of Three Cases
Jaime Aranda-Michel, MD; Alison Koehler, MD; Pablo A. Bejarano, MD; et al.
Ann Intern Med. 1999;130(4_Part_1):285-288. doi:10.7326/0003-4819-130-4-199902160-00013
Currents |  15 December 1998
Solid Organ Transplantation. 1: Many Problems, New Solutions
Paul Kefalides, MD
Ann Intern Med. 1998;129(12):1093-1095. doi:10.7326/0003-4819-129-12-199812150-00049
Diagnosis and Management |  1 December 1998
Diagnosis of Hemochromatosis
Lawrie W. Powell, MD; D. Keith George, MD; Sharon M. McDonnell, MD; et al.
Ann Intern Med. 1998;129(11_Part_2):925-931. doi:10.7326/0003-4819-129-11_Part_2-199812011-00002
Diagnosis and Management |  1 December 1998
Management of Hemochromatosis
James C. Barton, MD; Sharon M. McDonnell, MD, MPH; Paul C. Adams, MD; et al.
Ann Intern Med. 1998;129(11_Part_2):932-939. doi:10.7326/0003-4819-129-11_Part_2-199812011-00003
Population-Based Data |  1 December 1998
Prevalence of Elevated Serum Transferrin Saturation in Adults in the United States
Anne C. Looker, PhD; Clifford L. Johnson, MSPH
Ann Intern Med. 1998;129(11_Part_2):940-945. doi:10.7326/0003-4819-129-11_Part_2-199812011-00004
Population-Based Data |  1 December 1998
Hemochromatosis-Associated Mortality in the United States from 1979 to 1992: An Analysis of Multiple-Cause Mortality Data
Quanhe Yang, PhD; Sharon M. McDonnell, MD, MPH; Muin J. Khoury, MD, PhD; et al.
Ann Intern Med. 1998;129(11_Part_2):946-953. doi:10.7326/0003-4819-129-11_Part_2-199812011-00005
Screening |  1 December 1998
Prevalence of Hereditary Hemochromatosis in 16 031 Primary Care Patients
Pradyumna D. Phatak, MD; Ronald L. Sham, MD; Richard F. Raubertas, PhD; et al.
Ann Intern Med. 1998;129(11_Part_2):954-961. doi:10.7326/0003-4819-129-11_Part_2-199812011-00006
Screening |  1 December 1998
Iron Overload, Public Health, and Genetics: Evaluating the Evidence for Hemochromatosis Screening
Mary E. Cogswell, DrPH; Sharon M. McDonnell, MD, MPH; Muin J. Khoury, MD, PhD; et al.
Ann Intern Med. 1998;129(11_Part_2):971-979. doi:10.7326/0003-4819-129-11_Part_2-199812011-00008
Brief Communications |  15 November 1998
Oral Thymic Extract for Chronic Hepatitis C in Patients Previously Treated with Interferon: A Randomized, Double-Blind, Placebo-Controlled Trial
Robert S. Raymond, MD; Michael B. Fallon, MD; Gary A. Abrams, MD
Ann Intern Med. 1998;129(10):797-800. doi:10.7326/0003-4819-129-10-199811150-00009
Reviews |  15 October 1998
Treatment of Hepatocellular Carcinoma Associated with Cirrhosis in the Era of Liver Transplantation
Eytan Mor, MD; Ran Tur Kaspa, MD; Patricia Sheiner, MD; et al.
Ann Intern Med. 1998;129(8):643-653. doi:10.7326/0003-4819-129-8-199810150-00013
Brief Communications |  1 September 1998
Exhaled Nitric Oxide and Impaired Oxygenation in Cirrhotic Patients before and after Liver Transplantation
Giovanni Rolla, MD; Luisa Brussino, MD; Paola Colagrande, MD; et al.
Ann Intern Med. 1998;129(5):375-378. doi:10.7326/0003-4819-129-5-199809010-00005
Ideas and Opinions |  15 August 1998
Treating Histologically Mild Chronic Hepatitis C: Monotherapy, Combination Therapy, or Tincture of Time?
Robert A. Levine, MD
Ann Intern Med. 1998;129(4):323-326. doi:10.7326/0003-4819-129-4-199808150-00010
Articles |  15 July 1998
Relation of Interferon Therapy and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C
Yasuharu Imai, MD; Sumio Kawata, MD; Shinji Tamura, MD; et al.
Ann Intern Med. 1998;129(2):94-99. doi:10.7326/0003-4819-129-2-199807150-00005
Articles |  1 July 1998
Surgery for Recurrent Colon Cancer: Strategies for Identifying Resectable Recurrence and Success Rates after Resection
Richard M. Goldberg, MD; Thomas R. Fleming, PhD; Catherine M. Tangen, DrPH; et al.
Ann Intern Med. 1998;129(1):27-35. doi:10.7326/0003-4819-129-1-199807010-00007
Brief Communications |  1 July 1998
Two Cases of Severe Clinical and Histologic Hepatotoxicity Associated with Troglitazone
Norman Gitlin, MD; Neil L. Julie, MD; Charles L. Spurr, MD; et al.
Ann Intern Med. 1998;129(1):36-38. doi:10.7326/0003-4819-129-1-199807010-00008
Brief Communications |  1 July 1998
Troglitazone-Induced Hepatic Failure Leading to Liver Transplantation: A Case Report
Brent A. Neuschwander-Tetri, MD; William L. Isley, MD; Julie C. Oki, PharmD; et al.
Ann Intern Med. 1998;129(1):38-41. doi:10.7326/0003-4819-129-1-199807010-00009
Articles |  15 May 1998
Incidence of Hepatitis C in Patients Receiving Different Preparations of Hepatitis B Immunoglobulins after Liver Transplantation
Cyrille Feray, MD, PhD; Michele Gigou, MD; Didier Samuel, MD, PhD; et al.
Ann Intern Med. 1998;128(10):810-816. doi:10.7326/0003-4819-128-10-199805150-00003
Articles |  1 March 1998
Screening for Hemochromatosis and Iron Deficiency in Employees and Primary Care Patients in Western Germany
Claus Niederau, MD; Christoph M. Niederau, MD; Stefan Lange, MD; et al.
Ann Intern Med. 1998;128(5):337-345. doi:10.7326/0003-4819-128-5-199803010-00001
Brief Communications |  1 March 1998
Severe Hyperbilirubinemia after Creation of Transjugular Intrahepatic Portosystemic Shunts: Natural History and Predictors of Outcome
Smita S. Rouillard, MD; Nathan M. Bass, MD, PhD; John P. Roberts, MD; et al.
Ann Intern Med. 1998;128(5):374-377. doi:10.7326/0003-4819-128-5-199803010-00006
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)